EXAGEN INC. Operating Lease Liability
EXAGEN INC. (XGN) had Operating Lease Liability of $1.66 million as of 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-03-10
- 2025-12-31: Operating Lease, Liability $1.66M.
- 2024-12-31: Operating Lease, Liability $2.76M.
- 2023-12-31: Operating Lease, Liability $3.74M.
- 2022-12-31: Operating Lease, Liability $5.53M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $1.66M 10-K · filed 2026-03-10 |
| 2024-12-31 | $2.76M 10-K · filed 2025-03-11 |
| 2023-12-31 | $3.74M 10-K · filed 2024-03-18 |
| 2022-12-31 | $5.53M 10-K · filed 2023-03-20 |
| 2022-09-30 | $5.78M 10-Q · filed 2022-11-21 |
| 2022-06-30 | $6.01M 10-Q/A · filed 2022-11-21 |
| 2022-03-31 | $6.23M 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |